Not applicableUnknownNCT05040997
What this trial is testing
Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study)
Who this might be right for
Small Airway DiseaseAsthma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40